FINARO
22.3.2022 17:40:03 CET | Business Wire | Pressemeddelelse
Finaro , den globale indløser og bank, der er specialister indenfor international handel, har i dag offentliggjort Ruben Frimand Nielsen som Vicepræsident for Salg- og Forretningsudvikling for de Nordiske lande.
Tidligere business manager hos Mastercard, Ruben, vil lede vækststrategien i Danmark, Sverige, Norge, Finland, Færøerne, Island og Grønland, side om side med udvidelsen af det globale Finaro-team. Inden han sluttede sig til Finaro, var Ruben ansvarlig for international porteføljeadministration, salg og produktstrategi, for afdelingen payments international hos Mastercard. Derfor er han klar til at bringe Finaros globale betalingsløsninger ud til virksomheder i en af de hurtigst voksende e-handels regioner i Europa.
Danske, svenske, norske og finske forbrugere brugte tilsammen 46,5 milliarder euro online i 2020, med 19% af de nordiske handlende der foretog online indkøb på tværs af grænserne . I Danmark købte mere end 90% af forbrugerne ind online i 2020, efterfulgt af 87% i Norge og 86% i Sverige . Disse tal forventes at stige i 2022, da forbrugerne har vænnet sig til disse indkøbsmetoder og gør brug af mobil handel såsom lokale digitale wallets og in-app payments.
Achiya Fried, Chief Commercial & Strategy Officer hos Finaro , fortæller: “Jeg er begejstret for, at byde Ruben velkommen. Vi har ambitiøse vækstplaner, og en central del af dette omfatter udvidelser i de Nordiske lande. Rubens betalingserfaring og viden indenfor strategi vil helt sikkert blive en af drivkrafterne for Finaros voksende fremdrift i regionen, og jeg ser frem til, at se hvad han kan gøre for teamet og for virksomheden.”
Igal Rotam, CEO for Finaro , siger: “Vi er begejstrede for, at Ruben slutter sig til vores virksomhed for at støtte denne vækst og udføre den strategiske plan for de Nordiske lande. Hans kompetencer og dybdegående indblik vil sikre, at Finaros kunder på det Nordiske marked har adgang til de innovative og banebrydende betalingsløsninger, som de har behov for, for at kunne betjene deres egne voksende globale kunder.”
Ruben Frimand Nielsen, Vicepræsident for Salg - & Forretningsudvikling hos Finaro, kommenterede om sin nye titel og arbejde : “Det er en utrolig spændende tid at blive en del af Finaro på og være en del af den stærke vækst og ambitiøse planer for fremtiden. Den varme velkomst, og mit eksisterende kendskab til virksomheden samt produkterne har givet mig en smidig overgang - og jeg ser frem til, at påtage mig rollen for væksten samt at sætte et fodaftryk på det Nordiske marked. Jeg ser frem til at komme i gang.’’
Rubens udnævnelse kommer efter det nylige skift af Finaros navn fra Credorax, der afspejler dens nye identitet og forpligtelse til at realisere dens vision for betalinger, hvor handel er uden landegrænser og fri for teknologiske, fysiske og geografiske begrænsninger. Efter et utroligt succesfuldt år i 2021, med mere end 10 milliarder US dollars i samlet behandlet volume for mere end 5.000 handelsdrivende, er Finaro dedikeret til at gøre komplekse betalinger enkle, kombineret med dens instinktive passion for kundeservice, som går langt videre end det normale.
Om Finaro
Finaro er en global betalingsudbyder der på tværs af landegrænser styrker den internationale handel gennem enkle betalinger og innovativ teknologi. Vores dedikerede team, enestående teknologiske formåen, produktinnovation og kundefokuserede tilgang, gør os i stand til at forenkle kompleksitet og skabe samlet købsoplevelse der medfører vækst og giver ro i sindet for vores kunder. For at lære mere kan du besøge www.finaro.com .
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20220322005960/da/
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
